Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence

Fig. 1

a-c Kaplan–Meier curves for all patients. a Recurrence free survival; b progression free survival; c Treatment failure free survival. Tumor recurrence, progression and treatment failure differ significantly between these groups. Comparing with epirubin or pirarubicin group, gemcitabine group showed obvious advantage in inhibiting tumor recurrence, progression and treatment failure

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us